Trials / Recruiting
RecruitingNCT06961747
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
An Open-Label, Repeated-Dose Assessment of Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- UCB Biopharma SRL · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following injection of repeated once-daily doses of ZLP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zilucoplan | Dose formulation: Solution for injection. Route of administration: Subcutaneous injection. |
Timeline
- Start date
- 2025-07-09
- Primary completion
- 2027-03-23
- Completion
- 2027-03-23
- First posted
- 2025-05-08
- Last updated
- 2026-03-24
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06961747. Inclusion in this directory is not an endorsement.